8GN logo

Cessatech DB:8GN Stock Report

Last Price

€1.52

Market Cap

€29.7m

7D

-4.1%

1Y

161.2%

Updated

23 Dec, 2024

Data

Company Financials

8GN Stock Overview

Engages in identifying and developing drugs for the treatment of medical unmet need in children in Denmark. More details

8GN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Cessatech A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cessatech
Historical stock prices
Current Share PriceDKK 1.52
52 Week HighDKK 2.90
52 Week LowDKK 0.60
Beta0.36
1 Month Change-13.43%
3 Month Change-26.46%
1 Year Change161.21%
3 Year Change-29.04%
5 Year Changen/a
Change since IPO-46.09%

Recent News & Updates

Recent updates

Shareholder Returns

8GNDE PharmaceuticalsDE Market
7D-4.1%-2.2%-2.0%
1Y161.2%-15.8%6.8%

Return vs Industry: 8GN exceeded the German Pharmaceuticals industry which returned -15.6% over the past year.

Return vs Market: 8GN exceeded the German Market which returned 6.9% over the past year.

Price Volatility

Is 8GN's price volatile compared to industry and market?
8GN volatility
8GN Average Weekly Movement10.5%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.4%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8GN's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 8GN's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20204Jes Trygvedwww.cessatech.com

Cessatech A/S engages in identifying and developing drugs for the treatment of medical unmet need in children in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for magnetic resonance imaging scanning; and CT003, a local anesthetic gel.

Cessatech A/S Fundamentals Summary

How do Cessatech's earnings and revenue compare to its market cap?
8GN fundamental statistics
Market cap€29.67m
Earnings (TTM)-€2.35m
Revenue (TTM)€449.89k

65.9x

P/S Ratio

-12.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8GN income statement (TTM)
RevenueDKK 3.36m
Cost of RevenueDKK 0
Gross ProfitDKK 3.36m
Other ExpensesDKK 20.88m
Earnings-DKK 17.53m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.01
Gross Margin100.00%
Net Profit Margin-522.26%
Debt/Equity Ratio0%

How did 8GN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:02
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cessatech A/S is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution